News | MRI Breast | February 10, 2017

Rapid Breast MRI Screening Improves Cancer Detection in Dense Breasts

New method cuts screening time to 7 minutes while increasing early detection rates

A new method for screening women with dense breast tissue may potentially save thousands of lives

February 10, 2017 — A new method for screening women with dense breast tissue may potentially save thousands of lives by detecting breast cancer four to six years earlier than mammographic technology.

Due to its cost, breast imaging using magnetic resonance imaging (MRI) is recommended only for women at high risk for cancer — an estimated 2 percent of women. Mammograms are the current standard for the rest of the population.

The new Rapid Breast MRI protocol — derived from original research by David A. Strahle, M.D., chairman of Regional Medical Imaging in Flint, Mich. — cuts scan time by 70 percent to only 7 minutes, significantly reducing costs and enabling its use for screening women with dense breasts. In conjunction with a local HMO, Strahle found that early detection would have major costs savings for both women and insurance companies when considering the 10 categories of expense dealing with breast cancer.

Read the article "From Aviation to Breast Imaging - Development of an Abbreviated Breast MRI Protocol"

Mammographic technology for women with dense breast tissue is simply not as effective as MRI in spotting cancer, Strahle noted. In addition, unlike tomosynthesis (3-D mammography) or mammograms, MRIs do not use X-ray radiation.

“It’s like trying to see a thunderstorm through clouds without radar,” Strahle said. “MRI sees through the dense tissue, allowing radiologists to spot virtually all suspicious tumors.”

The new MRI protocol allows screening of women on a regular basis who have dense breast tissue. Strahle conducted peer-reviewed research of 671 women over seven years, which was published on Jan. 30, 2017. The research also includes an easier method for radiologists to read the exams, greatly lowering the false positive rate to below that of any other breast screening method.

Although insurance providers do not yet cover Rapid Breast MRI, the exam costs $395 out-of-pocket at RMI, compared with a diagnostic MRI that runs $700 or more. In addition to reducing scan time, screening Rapid Breast MRI can potentially be conducted every other year, instead of yearly as with mammograms. This equates to an annual cost of only $198, less than the average breast screening costs of $252 in mid-Michigan, Strahle said.

Read the article "Breast MRI in Cancer Diagnosis"

Breast cancer continues to be a leading cause of death in women. About one in eight women will develop breast cancer in their lifetimes, with 85 percent of those cancers occurring in women with no family history, according to breastcancer.org.

The research was published Jan. 30 in the journal Breast Cancer Research and Treatment.

For more information: www.link.springer.com

Related Breast MRI Content

VIDEO: Developments in Breast Density Legislation and Screening Guidelines

VIDEO: What is New in Breast Imaging Technology

Screening MRI Detects BI-RADS 3 Breast Cancer in High-risk Patients

References

Strahle, D.A., Pathak, D.R., Sierra, A., Saha, S., et al. "Systematic development of an abbreviated protocol for screening breast magnetic resonance imaging," Breast Cancer Research and Treatment. Published online Jan. 30, 2017. DOI: 10.1007/s10549-017-4112-0

Related Content

#SiemensHealthineers #Varian #Siemens The transformative combination accelerates the company’s impact on #global #healthcare and establishes a strong partner for #customers and #patients along the entire #cancer care continuum and for many of the most threatening #diseases
News | Radiology Business | April 15, 2021
April 15, 2021 — Siemens Healthineers AG an
Comparisons of high definition and standard definition infrared imaging for digital histopathology. Image courtesy of the Beckman Institute

Comparisons of high definition and standard definition infrared imaging for digital histopathology. Image courtesy of the Beckman Institute

News | Breast Imaging | April 14, 2021
April 14, 2021 — Detecting and analyzing breast cancer
A 37-year-old woman developed a new, palpable left supraclavicular lymphadenopathy lump five days after her first dose of the Moderna COVID-19 vaccine in the left arm. On the day of vaccination, the patient was asymptomatic. This is an example of how the vaccine can mimic cancer and swollen lymph nodes. Image used with permission of RSNA.

A 37-year-old woman developed a new, palpable left supraclavicular lymphadenopathy lump five days after her first dose of the Moderna COVID-19 vaccine in the left arm. On the day of vaccination, the patient was asymptomatic. This is an example of how the vaccine can mimic cancer and swollen lymph nodes. Read more about this case study. Image used with permission of RSNA.

Feature | Coronavirus (COVID-19) | April 09, 2021 | By Dave Fornell, Editor
While the mass COVID-19 vaccinat
3-D mammography reduces the number of breast cancer cases diagnosed in the period between routine screenings, when compared with traditional mammography, according to a large study from Lund University in Sweden. The results are published in the journal Radiology.

Getty Images

News | Breast Imaging | April 09, 2021
April 9, 2021 — 3-D mammography reduces the number of breast cancer cases diagnosed in the period between routine scr
Mobidiag Oy, a privately held, commercial-stage Finnish-French developer of innovative molecular diagnostic tests and instrumentation, announced today that it has signed a definitive agreement to be acquired by Hologic, Inc., a global leader in women's health, for an enterprise value of approximately $795 million.  This includes a cash payment of approximately $714 million for Mobidiag’s equity, and net debt of approximately $81 million.
News | Women's Health | April 08, 2021
April 8, 2021 — Mobidiag Oy, a privately held, commercial-stage F
Ultrasound is an invaluable diagnostic tool for the early detection of breast cancer, but the classification of lesions is sometimes challenging and time consuming. Could artificial intelligence hold the answer to solving these problems? Graphic courtesy of Chinese Medical Journal

Ultrasound is an invaluable diagnostic tool for the early detection of breast cancer, but the classification of lesions is sometimes challenging and time consuming. Could artificial intelligence hold the answer to solving these problems? Graphic courtesy of Chinese Medical Journal

News | Artificial Intelligence | April 06, 2021
April 6, 2021 — In 2020, the International Agency for Research on...
While the COVID-19 crisis is challenging, the pandemic is also giving researchers an opportunity to discover new approaches to saving lives. A study published in the JAMA Network Open on Thursday, March 25, 2021, recommends a new way for triaging mammogram patients during times of limited capacity, such as pandemic surges, when individuals may also experience anxiety about COVID-19.

Getty Images

News | Breast Imaging | April 01, 2021
April 1, 2021 — While the COVID-19 crisis is challenging, the pandemic is also giving researchers an opportunity to d
In looking at the broader impact of the COVID-19 pandemic on health and wellbeing, public health experts are examining screening rates for cancer. A new study looking at U.S. mammography screening rates during the first five months of the pandemic found both a strong rebound in breast cancer screening rates and a concerning cumulative deficit in mammograms due to missed appointments, as well as uncovering disparities when looking at screening according to race

Getty Images

News | Breast Imaging | April 01, 2021
April 1, 2021 — In looking at the broader impact of the...